Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
Use this ELAN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ELAN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ELAN SEC filings page. Lician reads the product cache first so this HTML stays unique to Elanco Animal Health even when a live quote feed is slow.
Latest cached year on this hub. Full ELAN income, balance, and cash tables.